Astrazeneca and the Global Coporate Challenge

The following case study describes the action AstraZeneca has taken to deliver on its commitments to pledges P1. Physical Activity: Community, P2. Physical Activity Guidelines, P3. Active Travel and P4. Physical Activity in the Workplace.

The Pharmaceutical Industry has a major part to play in improving health across the world. We all value our health but we know that a healthier world cannot come from medicines alone. AstraZeneca believes that a healthy workforce results in a productive, energised workplace that brings out the best in our employees. An important element of AstraZeneca’s health and wellbeing strategy is the on-going participation in the Global Corporate Challenge® (GCC)

AstraZeneca has taken part in the GCC for the past 6 years. The first of three GCC events start in May each year, where participants are taken on an incredibly entertaining 16 week virtual walking journey around the world. The GCC supports individuals to become more active by motivating them to take 10,000 steps a day – three times more than the average office-based worker walks. By encouraging employees to make simple, healthy and sustainable decisions during the 112 day challenge, the GCC encourages long-term positive behavioural change. This event is followed by the GCC Sprint in December and GCC Energy in February – all designed to encourage increased activity and energy levels.

Employee Benefits
The web based nature of the GCC means that the programme is inclusive of many of AstraZeneca’s employees around the world regardless of their geographic location. In 2013, 61% of AstraZeneca participants reported an increase in energy levels. Participants also reported an increase in their ability to handle stress. Weight loss is a welcome side-effect of the GCC with 57% of participants reporting losing weight.

Business Benefits
61% of employees felt that taking part in GCC had improved their energy levels with a number of participants reporting an increase in their productivity score.

In Summary
Not only has AstraZeneca’s involvement in the GCC been able to impact the overall health of employees but it has had a much wider reaching effect, to the benefit of the business as well.

To learn more visit or contact Amy LeBlanc +44 (0) 778 464 4134 or at

In Case studies | Tagged ,

Comments are closed.